Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
Transfusion
|
January 28, 2026
Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee (CTSCC) of Association for Advancement of Blood and Biotherapies (AABB)
Indira Guleria, Laura S Connelly-Smith, Asawari Bapat, et al.
American Journal of Hematology
|
August 4, 2018
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS
Omar Alkharabsheh, Aref Al-Kali, Salwa Saadeh, et al.
American Journal of Hematology
|
September 16, 2018
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
Omar Alkharabsheh, Salwa S Saadeh, Mrinal S Patnaik, et al.
British Journal of Haematology
|
May 26, 2022
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience
Naseema Gangat, Kristen McCullough, Aref Al-Kali, et al.
Blood Advances
|
July 23, 2024
Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience
Steven Tessier, Rong He, Patricia Greipp, et al.
Leukemia Research
|
June 7, 2025
Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms
Yazan Jabban, Rong He, Kurt Bessonen, et al.
Blood Cancer Journal
|
November 21, 2020
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
Prateek Pophali, Aasiya Matin, Abhishek A Mangaonkar, et al.
American Journal of Hematology
|
September 21, 2023
Mast cell cytomorphology and treatment outcome in mast cell leukemia
Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali, et al.
Blood Advances
|
November 21, 2024
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia
Talha Badar, Keith L Knutson, James Foran, et al.
Ejhaem
|
October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
Transfusion
|
January 28, 2026
Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee (CTSCC) of Association for Advancement of Blood and Biotherapies (AABB)
Indira Guleria, Laura S Connelly-Smith, Asawari Bapat, et al.
American Journal of Hematology
|
August 4, 2018
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS
Omar Alkharabsheh, Aref Al-Kali, Salwa Saadeh, et al.
American Journal of Hematology
|
September 16, 2018
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
Omar Alkharabsheh, Salwa S Saadeh, Mrinal S Patnaik, et al.
British Journal of Haematology
|
May 26, 2022
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience
Naseema Gangat, Kristen McCullough, Aref Al-Kali, et al.
Blood Advances
|
July 23, 2024
Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience
Steven Tessier, Rong He, Patricia Greipp, et al.
Leukemia Research
|
June 7, 2025
Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms
Yazan Jabban, Rong He, Kurt Bessonen, et al.
Blood Cancer Journal
|
November 21, 2020
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
Prateek Pophali, Aasiya Matin, Abhishek A Mangaonkar, et al.
American Journal of Hematology
|
September 21, 2023
Mast cell cytomorphology and treatment outcome in mast cell leukemia
Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali, et al.
Blood Advances
|
November 21, 2024
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia
Talha Badar, Keith L Knutson, James Foran, et al.
Ejhaem
|
October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Page
of 9